Taking selenium supplements for three months lowers a marker of oxidative damage (MDA) and raises the body’s overall antioxidant capacity in people with autoimmune thyroiditis who have normal thyroid function.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
Whether selenium supplementation consistently improves oxidative stress biomarkers (MDA, TAC, SOD) across diverse populations with autoimmune thyroiditis, and whether these changes correlate with clinical outcomes.
A systematic review and meta-analysis of all RCTs measuring MDA, TAC, and SOD before and after selenium supplementation (≥100 μg/day for ≥3 months) in adults with euthyroid autoimmune thyroiditis, stratifying by baseline selenium status and TPOAb levels, with pooled effect sizes and heterogeneity analysis.
Whether selenium supplementation directly causes sustained improvement in oxidative stress biomarkers in euthyroid autoimmune thyroiditis patients.
A double-blind RCT with 200+ euthyroid adults (TPOAb > 50 IU/mL) randomized to 200 μg/day selenium or placebo for 6 months, with primary endpoints being changes in plasma MDA, TAC, and SOD measured at baseline, 3, and 6 months, using standardized assays and blinded lab analysis.
Whether baseline oxidative stress levels predict the magnitude of TPOAb reduction following selenium supplementation over time.
A prospective cohort study following 300 euthyroid autoimmune thyroiditis patients for 2 years, measuring baseline MDA, TAC, and SOD, then tracking changes in these markers and TPOAb after selenium supplementation, adjusting for confounders like diet and smoking.
Whether patients with higher TPOAb titers have significantly worse oxidative stress profiles compared to those with lower titers.
A case-control study comparing 100 euthyroid autoimmune thyroiditis patients with TPOAb > 1000 IU/mL to 100 with TPOAb < 200 IU/mL, matched for age and BMI, measuring plasma MDA, TAC, and SOD at a single time point.
Whether there is a statistical association between serum selenium levels and oxidative stress markers in euthyroid autoimmune thyroiditis patients.
A cross-sectional analysis of 500 euthyroid autoimmune thyroiditis patients measuring serum selenium, plasma MDA, TAC, and SOD simultaneously, adjusting for dietary selenium intake and geographic region.